Institute for Global Prosperity

What Institute for Global Prosperity does

The Institute for Global Prosperity (IGP) is a research institute embedded within University College London (UCL), operating as part of a broader London-based academic institution that spans more than 18,000 staff and hosts 33 Nobel laureates. Its functional remit centres on interdisciplinary research into sustainable prosperity, drawing on UCL's wider expertise across the social and physical sciences to produce evidence-based outputs for policy and civic partners. IGP's business model is that of an academic research institute: funding flows from research grants, philanthropic contributions, and contract research routed through UCL's central administration, rather than from commercial product sales. Its customer base is primarily institutional — UK research councils, local government partners including the London Boroughs of Islington and Camden (with whom UCL has strategic partnerships and MOUs), philanthropic foundations, and policy stakeholders. Within UCL's broader portfolio, IGP sits alongside applied-AI initiatives (notably the 2025 NVIDIA sovereign-AI partnership), entrepreneurship infrastructure (BaseKX, supporting 600+ startups), and commercial spinouts (including the 2025 EpilepsyGTx $33M Series A). UCL's wider economic footprint includes a £900m+ supply-chain spend and major campus developments such as UCL East and the Manufacturing Futures Lab.

Name

Institute for Global Prosperity

Website

https://ucl.ac.uk

Company type

Private

Founded year

2014

Headcount range

11–50 employees

Short description

The Institute for Global Prosperity is a research institute within UCL conducting interdisciplinary research on sustainable prosperity, serving UK research councils, local government partners, and philanthropic funders through grant-funded and contract research activity.

Ownership category

akta.pro rank

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

Offering type

Services

Revenue model

1. Tuition Fees: UCL generates revenue from undergraduate and postgraduate tuition fees from students from over 150 countries. International student fees represent a significant revenue stream.
2. Research Grants and Contracts: Funding from UK Research Councils, government bodies, charitable foundations, and industry collaborations for research activities. UCL was ranked 2nd in the UK for research power in REF 2021.
3. Supply Chain Spend: UCL spends over £900m annually with its supply chain including third party suppliers of goods/services, research, professional services and teaching. This represents significant procurement volume.
4. Technology Transfer and Spinouts: Commercialization of research through spinout companies. UCLB manages spinouts including EpilepsyGTx which raised $33 million in Series A funding.
5. Theatre and Events Revenue: Bloomsbury Theatre generates revenue from ticket sales for theatre shows, live performances, comedy, music and events, including student discounts.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels6 records

Core offering

No information available about the Institute for Global Prosperity in the provided source data. The sources contain information about University College London (UCL) but do not describe the Institute for Global Prosperity's offerings.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• UCL gained its 33rd Nobel laureate in 2025 with Professor Philippe Aghion's Nobel Prize in Economic Sciences
• +6 more outcomes

Named customers3 records

Segments4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

14 partnerships are on record, tiered core and minor.

• NVIDIAcoreTechnology or Integration · 1 June 2025UCL announced as UK partner of NVIDIA for chip designer's Europe-wide initiative to help countries develop their own sovereign AI systems. Part of company's initiative to establish AI infrastructure partnerships across Europe.
• London Borough of Islington CouncilcoreStrategic or Co-development Partner · 14 November 2023Formal strategic partnership signed in November 2023 with a Memorandum of Understanding coordinated through the UCL London Office. Two years on, more than 80 projects have been delivered involving 340 staff and students across 35 teams. Partnership aims to shape a more equitable future for Islington.
• London Borough of Camden CouncilcoreStrategic or Co-development Partner · 15 December 2020Joint Memorandum of Understanding signed in December 2020 formalizing a partnership spanning many years. Partnership coordinated through the UCL London Office with focus on community engagement and local impact.
• London Borough of Newham CouncilcoreStrategic or Co-development PartnerPartnership with Newham Council focused on East London communities and the UCL East campus at Queen Elizabeth Olympic Park. Two years of partnership celebrated, with multiple collaborative projects underway.
• British LandcoreStrategic or Co-development PartnerStrategic partnership to support innovation and life sciences in the Knowledge Quarter. Partnership aims to accelerate innovation and life sciences, reinforcing dedication to supporting science within the community.
• Knowledge QuartercoreStrategic or Co-development PartnerEurope's largest innovation district. Professor Alan Thompson, Pro-Provost (London), appointed as Chair of the Knowledge Quarter Board, providing strategic leadership and governance oversight.
• East Bank ConsortiumcoreStrategic or Co-development PartnerEast Bank partnership with V&A East, Sadler's Wells East, BBC, and London College of Fashion UAL for cultural programming including The Music Is Black Festival. UCL contributes talks, screenings, and academic expertise.
• Great Ormond Street Hospital (GOSH)coreStrategic or Co-development PartnerClinical research partnership for pediatric treatments including base-edited gene therapy developed by Professor Waseem Qasim that reversed previously incurable blood cancer in children.
• Moorfields Eye HospitalcoreStrategic or Co-development PartnerClinical partnership for eye disease research including gene therapy for inherited blindness and electronic eye implant clinical trials.
• Autolus TherapeuticscoreTechnology or IntegrationUCL spinout developing CAR T-cell therapy for treatment of severe, treatment-resistant lupus. Therapy developed with UCL and UCLH showing early promise in clinical trials.
• CoramminorStrategic or Co-development PartnerMOU signed between UCL and Coram, the children's charity, coordinated through the UCL London Office for collaboration on child welfare and education initiatives.
• UCL AcademyminorStrategic or Co-development PartnerUCL Academy is a secondary school in Camden founded by UCL. Professor Lucie Green serves as Chair of Governors. Partnership includes student engagement, poster exhibitions, and campus visits.
• Mercedes Formula OneminorStrategic or Co-development PartnerCollaboration during COVID-19 pandemic to rapidly design and produce low-cost ventilators. UCL engineers worked alongside Mercedes Formula One to develop breathing support devices.
• BusinessLDNminorStrategic or Co-development PartnerPartnership with Business London's organization representing London businesses for economic development and business support initiatives.

Scale indicators13 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• New York University (NYL): Global research university with strong London/global presence, comparable scale, and emphasis on internationalization. Comparable in multidisciplinary research, urban campuses, and global student demographics.
• ETH Zurich: European public research university consistently ranked in the global top 10, with strong STEM and life sciences research. Comparable in research intensity, discipline breadth, and ability to attract international talent.
• University of Cambridge: Top UK research university with similar scale, Nobel laureate history, and global student base. Direct competitor for students, faculty, and research partnerships.
• London School of Economics and Political Science (LSE): London-based specialist research university, also a member of the University of London ecosystem. Comparable in international student mix, central London positioning, and global rankings in social sciences.
• King's College London: London-based research university with similar discipline breadth, central London location, and NHS-linked clinical research portfolio. Competes directly for students and London partnerships.
• University of Oxford: Top UK research university with comparable multidisciplinary scope, research power, and international reputation. Direct competitor for faculty, research funding, and global rankings.
• Imperial College London: London-based global research university with similar scale, STEM strength, and international student base. Both compete for top global rankings, research grants, and international recruitment in London.
• University of Manchester: Large UK research university with comparable scale, comprehensive discipline mix, and Russell Group membership. Direct competitor for research funding and postgraduate talent.
• University of Toronto: Major public research university in a global city with comparable scale, research power, and international student base. Comparable in translational medicine, AI partnerships, and global ranking trajectory.
• University of Edinburgh: Major UK research university with comparable scale, research power, and international student mix. Competes for global rankings, research grants, and European/global partnerships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Customer concentration

• Xx.com/ucl
• Facebookfacebook.com/uclofficial
• LinkedInlinkedin.com/company/ucl-institute-for-global-prosperity

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Institute for Global Prosperity